Hagan Pushes Bill To Accelerate Drug Approval
Hagan says the Food and Drug Administration needs to find faster ways to get treatments to patients suffering from rare diseases.
Kay Hagan: To have a clinical trial with a thousand patients for some of these rare diseases would take 20 years. And if they can come up with an accelerated approval process where they can have a trial with a much much smaller group of patients, then that's one way.
Hagan says insuring the safety of drugs would still be a top priority, and more comprehensive trials would continue after a treatment is fast-tracked. The Democratic lawmaker calls the bill the most bipartisan one she's ever worked on and she says she's confident it will pass when it's brought up for a vote soon.